Our Team

We are scientist-entrepreneurs dedicated to discovering new therapeutic agents for Alzheimer’s patients.

A stylized portrait of Kelvin Lam with glasses and a colored button-up shirt.

Kelvin Lam

A leading expert in early drug discovery, Dr. Lam guides target identification, lead optimization, and preclinical validation for MCM6’s therapeutic programs.

LinkedIn

Co-Founder & COO
A portrait of Matthew Stremlau smiling man with glasses, wearing a light-colored button-up shirt, against a dark background.

Matt Stremlau

Dr. Stremlau leads the strategic translation of APOE4 biology into targeted therapeutics for Alzheimer’s disease and related disorders.

LinkedIn

Co-Founder & CEO
A portrait of Miranda Yang with dark hair and light skin, wearing a black top and a pearl necklace, against a dark background.

Professor Yang serves as an Advisor to MCM6 and leads the iPS cell-based technology and 3D miBRAIN biological platforms, including project management, at the Icahn School of Medicine at Mount Sinai.

LinkedIn

Co-Founder & Assistant Professor

Miranda Yang

A portrait of Joel Blanchard, wearing a black zip-up jacket and white T-shirt, against a dark background.

MCM6 was built upon the foundational scientific contributions of the Blanchard Lab at the Icahn School of Medicine at Mount Sinai.

Professor Blanchard continues to provide strategic scientific guidance to MCM6. He collaborates closely with other world-renowned neuroscientists and bioengineering experts.

Advisor & Associate Professor

Joel Blanchard